The University of Cambridge is launching its second enterprise fund for the 2013-14 tax year to support the University’s commercialisation efforts with the target of raising £1.5m ($2.2m).

The first fund made three investments (Cambridge CMOS Sensors, DefiniGEN, and Inotec AMD) during November last year. Then last month, it took part in a $2.5m series A for Sphere Fluidics, a Cambridge life sciences spin-out, led by private equity firm 24Haymarket with participation from the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?